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INTRODUCTION
Major affective disorders are one of the
foremost causes of morbidity worldwide;
such disabling conditions are also fre-
quently associated with suicidal behavior
(Innamorati et al., 2011; Gonda et al.,
2012; Serafini et al., 2012). Although many
psychopharmacological agents are cur-
rently available, in particular for the treat-
ment of major depressive disorder (MDD)
(Serafini et al., 2013), our knowledge con-
cerning the molecular and cellular mecha-
nisms underlying this complex condition
is still limited. Indeed, even minor alter-
ations in the expression of genes regulat-
ing neural and structural plasticity may be
crucial to understanding the pathogenesis
of major affective disorders (Dwivedi et al.,
2009a,b; Serafini et al., 2011, 2012).
MiRNAs are gene expression regula-
tors critically affecting brain development
that have been investigated as potential
biomarkers for the diagnosis, manage-
ment, treatment, and progression of neu-
ropsychiatric disorders (Machado-Vieira
et al., 2010; Saugstad, 2010; Dwivedi,
2011). Several facets of miRNA expression
alterations are currently under investiga-
tion to gain insight into the pathology of
neuronal disorders (Hansen et al., 2007;
Lopez et al., 2013): miRNA expression
alterations in pathophysiological models
of disease (Ziu et al., 2011; Brandenburger
et al., 2012); miRNA expression alter-
ations in the blood of patients, most
of which represent further downstream
or compensatory effects (Schipper et al.,
2007; Gallego et al., 2012); and miRNAs
and their effectors acting as targets for
the action of psychoactive drugs such
as antidepressants and mood stabilizers
(Zhou et al., 2009; Baudry et al., 2010;
Oved et al., 2012).
Several miRNAs have emerged
as potential mediators of depressive
pathophysiology. The existence of poly-
morphisms in pre-miR-30e (Xu et al.,
2010) and pre-miR-182 (Saus et al., 2010)
has been associated with an increased risk
of major depression. Depressive behav-
ioral responses have been induced by
miR-16 up-regulation in the raphe nuclei
and hippocampus, with the latter associ-
ated with subsequent down-regulation of
BNDF (Bai et al., 2012). MiR-16 down-
regulation within the locus coeruleus was
also induced in depressive mouse mod-
els (Launay et al., 2011). Smalheiser et al.
(2012) investigated the expression of miR-
NAs in the prefrontal cortex (specifically
in Brodmann Area 9) of 18 antidepressant-
free depressed suicide victims, and 17
well-matched non-psychiatric controls,
whose information was collected using
the psychological autopsy method. In this
study, global miRNA expression was sig-
nificantly down-regulated by 17%, and
24 miRNAs were down-regulated by at
least 30%. The authors also found sig-
nificant down-regulation in an extensive
inter-connected network of 21 miRNAs
involved in cellular growth and dif-
ferentiation. Notably, both the global
decrease of miRNA expression, as well
as its decreased variability, are consistent
with hypo-activation of the frontal cortex
in depressed subjects. Interestingly, the
noted miRNAs have been suggested to
be down-regulated in the frontal cortex
of rats treated with corticosterone, and
therefore, might be crucial in regulat-
ing stress-mediated miRNA expression in
depressed subjects (Dwivedi et al., unpub-
lished data). Hence, alterations in miRNA
expression may be a fundamental event
underlying gene network reorganization
associated with major depression.
Nevertheless, a comprehensive under-
standing of miRNA networks dysregu-
lated in major depression and induced
by antidepressant medications as a func-
tion of brain region is currently unknown
(Mouillet-Richard et al., 2012). It is also
generally poorly understood how miRNA
regulation affects cellular signaling net-
works in these biological processes. Here
we provide an overview and critical review
of the published work, particularly exam-
ining the role of miR-185 in major depres-
sion and suicidal behavior.
THE CHALLENGES OF miRNA:mRNA
TARGET PREDICTION IN MODELING
PATHOLOGY
Expression profiling and RNA sequenc-
ing of miRNAs have increased our under-
standing of which miRNAs are present in
specific tissues, and how they may change
under pathological conditions (Oved et al.,
2012). However, once identified, linking
a miRNA to its mRNA targets can be
a challenging task, and the authenticity
of functional miRNA:mRNA target pairs
should be validated. A very small fraction
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of software-predicted miRNA targets are
validated in vivo. As suggested by Kuppers
et al. (2011), only a subset of predicted
targets are consistently reduced in phe-
notypes that overexpress some miRNAs.
Validation could be provided by showing a
direct interaction between the miRNA and
mRNA target. Further, miRNA silencing,
overexpression, and luciferase reporter
based assays are commonly used as sup-
porting evidence for a functional interac-
tion (Kuhn et al., 2008).
Many databases for miRNA target pre-
diction have been created using an array
of interrogation approaches. Considering
varying degrees of sequence similarity,
conservation, site accessibility, and vari-
ation in the targeted regions of the
mRNA, the numerous databases can pro-
vide a surprising level of divergent results.
This divergence speaks to the difficulty
that scientists have had in developing a
clear and concise set of rules underlying
miRNA:mRNA interaction: clearly target
prediction software should only be viewed
as a tool to guide bench science.
Table 1 Provides a summary of cur-
rent miRNA target prediction software
that may be used to guide in silico inves-
tigations into miRNA and their putative
targets. The analytical paradigms for each
database are describes as well as advantages
of each mode of inquiry.
MiR-185: A ROLE IN MAJOR AFFECTIVE
DISORDERS AND SUICIDAL
BEHAVIOR?
Preliminary studies have suggested the
importance of miR-185 and miR-491-
3p in the pathogenesis of major depres-
sion and suicidal behavior. MiR-185 is
expressed in several brain regions such
as the hippocampus and cortex, predom-
inantly in synapses (Lugli et al., 2008; Xu
et al., 2013). Earls et al. (2012) reported
that miR-185 regulates cognitive and psy-
chiatric symptoms of patients with the
22q11 deletion syndrome. Recently, Xu
et al. (2013) suggested that miR185 con-
trols the expression of Golgi-apparatus
related genes including a new inhibitor
of neuronal maturation. In particular, a
reduction of miR-185 altered dendritic
and spine development resulting in struc-
tural alterations of the hippocampus.
With respect to MDD and suicidality,
miR-185 was shown to be upregulated in
patients who completed suicide (Maussion
et al., 2012). These increases in expres-
sion were correlated with reduced TrkB-
T1, a truncated TrkB transcript whose
downregulation has been associated with
suicide (Ernst et al., 2009). The down-
regulation of TrkB-T1was associated with
suicidal behavior in a sample of 38 sui-
cide completers (60.5% having been previ-
ously diagnosed with MDD). Of note, five
putative binding sites for miR-185 were
found in the 3′ UTR of TrkB-T1 (using
an in silico investigation). Array findings
were confirmed with RT-PCR investiga-
tion and three of the five potential bind-
ing sites for miR-185 in the TrkB-T1 3′
UTR were demonstrated to be functional
by luciferase assay. The authors did not
find any confounding effect of age, pH,
PMI, or suicide method. Through Pearson
correlation and subsequent in vitro func-
tional analyses (using silencing or exoge-
nous expression of miR-185), TrkB-T1 lev-
els and hsa-miR-185 levels were reported
to be inversely correlated.
A few notes of caution should be
mentioned with regard to the Maussion
et al. (2012) study. The authors acknowl-
edge that the underlying mechanism of
increased miR-185 expression remains
unclear. The study used HEK293 cells that
yielded TrkB-T1 expression levels that
were 10-fold greater than neuronal cell
lines. Furthermore, RNA binding pro-
teins, such as ELAVL1 or PABPC1, may be
expressed in HEK293 cells (Drury et al.,
2010) and potentially bind TrkB mRNA
(Jain et al., 2011). Therefore, despite
disproportionate increases in TrkB-T1
expression, the functional effect of hsa-
miR-185 on TrkB-T1 observed in HEK293
cells might have been attenuated by the
expression of these genes and their binding
activity (George and Tenenbaum, 2006).
Further, the study is limited by the small
sample size and the negative findings in
other brain regions, such as the cerebel-
lum. Indeed, presumably only a limited
part of the total variability in miRNAs
that might regulate TrkB-T1 has been
identified.
Of note, the subjects of the Maussion
et al. (2012) study were not assessed for
microduplications in the 22q11.2 region.
This is of potential interest because the
miR-185 locus maps to the 22q11.2 region,
which has been associated with mood
disorders such as depression and anxiety
(Jolin et al., 2012; Weisfeld-Adams et al.,
2012; Tang et al., 2013). Deletions of this
region have also been consistently asso-
ciated with schizophrenia (Karayiorgou
et al., 2010) whereas duplications have
been found in patients with autism
(Lo-Castro et al., 2009). Alterations in
the 22q11.2 region are also associated
with morphological alterations in den-
dritic spines at glutamatergic synapses
(Mukai et al., 2008), and abnormal mat-
uration of miRNAs (Stark et al., 2008).
Fénelon et al. (2013) have suggested that
mice with a 22q11.2 microdeletion show
significant alterations in high-frequency
synaptic transmission, short- and long-
term plasticity, and dendritic spine sta-
bility. The authors reported that varia-
tion in synaptic plasticity occurs by sub-
tle changes in neuronal density and a
reduction in inhibitory neuron. All of
these alterations in neuronal function
could play critical roles in depressive
pathophysiology.
UNDERSTANDING THE LIMITATIONS
OF STUDIES EXAMINING THE ROLE OF
miRNAs IN MAJOR AFFECTIVE
DISORDERS
Since the first detection in Caenorhabditis
elegans in 1993 (Lee et al., 1993), small
interfering RNAs have raised great interest
among neurobiologists for their potential
role in neuropathological regulation. In
line with this notion, large-scale anal-
yses on post-mortem brains, as well
as investigations in animal models of
depression, have evaluated the impact
of psychoactive medications on global
miRNA expression. Transcriptome studies
are now commonly used as a starting point
to investigate the association between
dysregulated miRNAs and major affective
disorders. However, there are a number
of conflicting studies with regard to the
magnitude and direction of biologically-
relevant miRNA expression changes in
psychiatric disorders (Perkins et al., 2007;
Beveridge et al., 2010). This could be due
to tissue-specific variations in expression
levels as well as heterogeneity in quan-
tification and normalization procedures
(Belzeaux et al., 2012). Furthermore,
some studies on miRNAs and depres-
sion were conducted in peripheral blood
despite uncertainties regarding how
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Table 1 | Comprehensive list of miRNA target databases and software.
Databases for
miRNAs and
their target
gene
associations
Description Release
date of the
last version
Web link Publication
DIANA–microT This is an algorithm specifically trained on a positive and
negative set of miRNA Recognition Elements (MREs) located in
both the 3′-UTR and CDS regions. This new server detects
miRNA targets in mRNA sequences of Mus musculus,
Drosophila melanogaster, C.elegans, and Homo sapiens. It also
provides hyperlinks to on-line servers such as iHOP and
expression data for the selected miRNAs in tissues and cell
lines. Each gene is weighted considering conserved as well as
non-conserved sites. Furthermore, a signal to noise ratio is
applied for each interaction in order to estimate the number of
false positives.
Jul, 2012
(version 5.0)
http://www.
microrna.gr/
microT-CDS
Reczko et al. (2012)
MicroCosm This is a miRNA target database that has been developed by
Enright lab at EMBL-EBI. MicroCosm Targets includes
computationally predicted microRNA targets for many species
and is based on a dynamic program to search for maximal local
complementarity alignments. The miRNA sequences are
derived by the miRBase Sequence database and most genomic
sequence from EnsEMBL. MicroCosm uses the miRanda
algorithm that is one of the first miRNA target prediction
algorithms.
Ago, 2010
(version v5)
http://www.
ebi.ac.uk/
enright-srv/
microcosm/
htdocs/targets/v5/
Griffiths-Jones et al. (2008)
miRanda and
microRNA.org
It includes both software (miRanda) and a miRNA database
(microRNA.org). This algorithm uses a score to rank the
predictions according to a weighted sum based on matches,
mismatches, and G:U wobbles. The newest version of MiRanda
is also called mirSVR, it also considers a conservation measure
based on the PhastCons conservation score.
Ago, 2010 http://www.
microrna.org/
microrna/home.do
Betel et al. (2008)
miRDB All the targets are predicted by the bioinformatics tool
MirTarget2, which analyzes thousands of genes impacted by
miRNAs with an SVM learning machine. MiRDB includes
predicted miRNA targets from the following organisms:
humans, mouse, rat, dog, and chicken. MiRNA targets are
predicted using common features associated with miRNA
target binding. The positive and negative datasets for training
consist of many negative and positive interactions, respectively.
Jan, 2012
(version 4.0)
http://mirdb.org/
miRDB/
Wang and El Naqa (2008)
miRecords This is an integrated microRNA target database for
miRNA–target interactions. It provides miRNA-target
relationships predicted by multiple target algorithms, such as
Targetscan, PicTar, miRanda, PITA, and RNA22. It provides a
large manually curated database including experimentally
validated miRNA–target interactions with systematic
documentation of experimental support for each interaction. It
is expected to serve for experimental miRNA researchers, and
informatics scientists.
Apr, 2013 http://mirecords.
umn.edu/
miRecords/
Xiao et al. (2009)
miRGator This is an algorithm integrating the target prediction, functional
analysis, gene expression data, and genome annotation. MiRNA
function is inferred from the list of target genes predicted by
other databases (miRanda, PicTar, and TargetScanS). For the
expression analysis, miRGator integrates public expression
findings of miRNAs with those of mRNAs and proteins.
Dic, 2012
(version 3.0)
http://genome.
ewha.ac.kr/
miRGator/
miRGator.html
Nam et al. (2008)
(Continued)
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Table 1 | Continued
Databases for
miRNAs and
their target
gene
associations
Description Release
date of the
last version
Web link Publication
miRGen++ miRGen is an integrated database including positional
relationships between animal miRNAs and genomic
annotation sets as well as animal miRNA targets, according
to combinations of widely used target prediction programs. It
provides comprehensive information about the position of
human and mouse microRNA coding transcripts and their
regulation by transcription factors.
Jan, 2007
(version 3)
http://www.diana.
pcbi.upenn.edu/
miRGen.html
Megraw et al. (2006)
MiRNAMap This is an integrated database aimed to identify
experimentally verified miRNA target genes in human,
mouse, rat, and other metazoan genomes. MiRNA targets in
3′-UTR of genes and the miRNA targets were identified using
the following computational tools: miRanda, RNAhybrid, and
TargetScan. The putative miRNA targets are adequately
filtered in order to reduce the false positive prediction rate of
miRNA target sites.
Jul, 2007
(version 2.0)
http://mirnamap.
mbc.nctu.edu.tw/
Hsu et al. (2008)
miRTarBase This is an experimentally verified miRNA target base,
including more than 3000 miRNA–target interactions
collected by manually surveying pertinent literature.
Generally, the collected miRNA–target interactions are
validated experimentally based on reporter assays, western
blot, or microarray experiments with overexpression or
knockdown of miRNAs.
Jul, 2013
(version 4.3)
http://miRTarBase.
mbc.nctu.edu.tw/
Hsu et al. (2011)
miRWalk miRWalk is a comprehensive database providing information
on miRNAs from human, and mouse, including their
predicted and validated binding sites for their target genes.
MiRWalk considers a newly developed algorithm aimed at
creating the predicted miRNA binding sites on the complete
sequences of all known genes of the human, mouse, and rat
genomes. It provides predicted miRNA binding sites on
genes associated with over 400 human biological pathways
and over 2300 OMIM disorders. It also includes information
on proteins known to be implicated in miRNA processing.
Mar, 2011 http://www.umm.
uni-heidel-
berg.de/apps/zmf/
mirwalk/
Dweep et al. (2011)
PicTar PicTar is used for the identification and prediction of miRNA
targets by combining multiple miRNAs or targets. This
website provides details concerning: miRNA target
predictions in vertebrates; miRNA target predictions in seven
Drosophila species; miRNA targets in three nematode
species; human miRNA targets that are not conserved but
co-expressed (e.g., both the miRNA and mRNA that are
expressed in the same tissue).
Mar, 2007 http://pictar.
mdc-berlin.de/
Lall et al. (2006)
PITA This algorithm predicts miRNA targets taking into account
not only the specific duplex interaction information, but also
the accessibility (the difference between the minimum free
energy of the whole complex and the initial energy of a short
mRNA region near the site) to the site in the mRNA. Several
restrictions may be applied to reduce the set of resulting
predictions.
Ago, 2008
(version 6)
http://genie.
weizmann.ac.il/
pubs/mir07/mir07
_data.html
Kertesz et al. (2007)
(Continued)
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Table 1 | Continued
Databases for
miRNAs and
their target
gene
associations
Description Release
date of the
last version
Web link Publication
RNA22 It is a pattern-based strategy aimed to identify the candidate
targets. A Markov chain is used to identify those patters which
are hypothesized to identify areas where the most statistically
significant patterns map (target islands). The target islands are
subsequently paired with miRNAs.
May, 2008
(version
1.1.2)
http://cbcsrv.
watson.ibm.com/
rna22.html
Miranda et al. (2006)
RNAhybrid This algorithm provides a flexible software for predicting
miRNA targets. It is a tool that finds the minimum free energy
not only for short sequences as most of the mentioned
algorithms, but also for the entire miRNA–mRNA. The analysis
is carried out by hybridizing the short sequence to the best
fitting part of the long sequence. Several restrictions like the
number of unpaired bases and free energy allowed may be
applied to reduce the set of resulting predictions.
Jul, 2013
(version
2.1.1–2)
http://bibiserv.
techfak.
uni-bielefeld.
de/rnahybrid/
Kruger and Rehmsmeier
(2006)
StarBase This algorithm provides a public platform developed to facilitate
the comprehensive exploration of miRNA–target interaction
from CLIP-Seq (HITS-CLIP, PAR-CLIP) and degradome
sequencing (PARE) data from the following organisms: human,
mouse, Caenhorhabditis elegans, Arabidopsis thaliana, Oryza
sativa, and Vitis vinifera. It also provides intersections of
multiple target predictions, such as Targetscan, PicTar,
miRanda, PITA, RNA22, and miRSVR.
Sep, 2011
(version 2.1)
http://starbase.
sysu.edu.cn/
Yang et al. (2011)
TarBase This is a large available target database including more than
65,000 miRNA-gene interactions. It includes targets derived
from both microarrays and proteomics. It is linked to other
databases such as Ensembl, Uniprot, RefSeq, and
DIANA-microT enabling extension of each validated interaction
with in silico predicted information.
Jan, 2009
(version 6.0)
http://microrna.gr/
tarbase/
Vergoulis et al. (2012)
TargetRank TargetRank scores the seed matches in a UTR relative to a
given siRNA or miRNA and then calculates an overall score for
the mRNA as a whole by summing the scores for all seed
matches present in the 3′ UTR. Only targets with scores above
0.2 are reported. The relative ranking given by TargetRank may
be considered more useful than the score itself.
Mar, 2006 http://genes.mit.
edu/targetrank/
Nielsen et al. (2007)
TargetScan This algorithm requires the seed complementary at least for 6
nt and considers the different seed types that have been
defined using a specific hierarchy. It predicts microRNA targets
from conserved UTR sequences by searching for the presence
of conserved and non-conserved sites matching the seed
region of each miRNA. In the last version of this algorithm, a
multiple linear regression trained on 74 filtered datasets has
been used to integrate determinants.
Mar, 2012
(version 6.1)
http://www.
targetscan.org/
Friedman et al. (2009)
closely changes in peripheral miRNA
expression reflect modifications in the
central nervous system (e.g., Bocchio-
Chiavetto et al., 2013). It is also worth
noting that, “control” RNAs commonly
used to normalize miRNA data (U6,
U44, and U48) are very sensitive to post-
mortem decay (Sadikovic et al., 2011)
and thus, should be carefully matched
among groups to prevent the emergence
of artifactual shifts in miRNA expression.
Finally, neuronal shrinkage, loss of glial
cells, or loss of dendritic spines may also
contribute to changes in miRNA levels.
Clearly, changes in tissue composition or
cellular compartments should be carefully
taken into account when examining the
available studies.
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CONCLUSION
Our understanding of the molecular
mechanisms underlying major affective
disorders may be significantly enriched by
the knowledge of miRNAs’ mechanisms
of action. MiRNA targets are criti-
cally involved in stress-related disorders,
neuroplasticity, and neurodevelopmental
disorders (Rogaev, 2005). Given that miR-
NAs have been hypothesized to modulate
∼50% of protein-coding genes and hun-
dreds of mRNAs (Krol et al., 2010), a new
level of complexity regarding gene expres-
sion has emerged. The entire miRNA
context (both mRNA networks and their
cellular environments) should be critically
investigated when interpreting the effects
of changes in miRNA levels. Much remains
to be examined in order to translate these
investigations into novel therapeutics for
the treatment of psychiatric conditions.
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